Raymond F Schinazi

Decatur, GA, United States of America

Raymond F Schinazi

wikipedia
USPTO Granted Patents = 124 

 

 

Average Co-Inventor Count = 2.8

ph-index = 30

Forward Citations = 2,614(Granted Patents)


Inventors with similar research interests:


Location History:

  • Tucker, GA (US) (1987 - 1993)
  • Decatur, GA (US) (1991 - 2018)
  • Atlanta, GA (US) (2009 - 2024)
  • Miami, FL (US) (2014 - 2024)

Company Filing History:

goldMedal91 out of 986 
 
Emory University
 patents
silverMedal19 out of 843 
 
University of Georgia Research Foundation, Inc.
 patents
bronzeMedal6 out of 16 
 
Cocrystal Pharma, Inc.
 patents
44 out of 19 
 
Pharmasset, Inc.
 patents
54 out of 201 
 
Georgia State University Research Foundation, Inc.
 patents
64 out of 15,458 
 
University of California
 patents
74 out of 889 
 
The United States Government As Represented by the Department of Veterans Affairs
 patents
83 out of 6 
 
Rfs Pharma LLC
 patents
93 out of 580 
 
The Uab Research Foundation
 patents
103 out of 516 
 
University of Alabama
 patents
113 out of 197 
 
Oklahoma Medical Research Foundation
 patents
123 out of 516 
 
Beth Israel Deaconess Medical Center, Inc.
 patents
132 out of 5,069 
 
Centre National De La Recherche Scientifique
 patents
141 out of 5,303 
 
Leland Stanford Junior University
 patents
151 out of 1,860 
 
University of Pittsburgh
 patents
161 out of 63 
 
Cnrs
 patents
171 out of 1,325 
 
Yale University
 patents
181 out of 53 
 
Aktiebolaget Astra
 patents
191 out of 2,007 
 
Duke University
 patents
201 out of 80 
 
Children's Healthcare of Atlanta, Inc.
 patents
211 out of 3,923 
 
Novartis Ag
 patents
2220 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1987-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Antiviral Jak Inhibitors
Nucleoside Analogs
Peptidomimetics
Hiv-1 Treatment
Hepatitis C Inhibitors
Norovirus Treatment
Metabolic Disorders
Zika Virus Treatment
Retroviral Infections
Coronaviridae Infections
Flaviviridae Family
Cancer Treatment
124 patents (USPTO):Explore Patents

Title: Raymond F Schinazi: A Distinguished Leader in the Field of Medical Research and Innovation

Introduction:

Raymond F Schinazi's remarkable career has been marked by a multitude of achievements and accolades in the field of medical research and innovation. With an extensive background in academia and research, he has contributed significantly to the advancements in the treatment of viral infections, including hepatitis, HIV, and cancer. This article explores Raymond F Schinazi's latest patents, career highlights, notable collaborations, and his indelible impact on the medical field.

Latest Patents:

Raymond F Schinazi's groundbreaking research has led to numerous patented innovations. His latest patents showcase his commitment to finding novel treatments for various diseases:

1. 2′ Fluoronucleosides:

These compounds, disclosed in his patent, are instrumental in treating hepatitis B infection, hepatitis C infection, HIV, and abnormal cellular proliferation, including tumors and cancer. With their unique chemical structures, these compounds have demonstrated potential in combating these challenging health conditions.

2. Treatment of EBV and KHSV infection and associated abnormal cellular proliferation:

Raymond F Schinazi's patent covers a method and composition for treating, preventing, and/or prophylaxis of individuals infected with Epstein-Barr virus (EBV). The patent highlights the administration of an effective amount of a 5-substituted uracil nucleoside or its pharmaceutically acceptable salt or prodrug. This innovation offers promising prospects in combating EBV infections and associated abnormal cellular growth.

Career Highlights:

Throughout his illustrious career, Raymond F Schinazi has held various academic and research positions, solidifying his expertise in the medical field. Some of his notable career highlights include:

1. Professor of Pediatrics and Chemistry at Emory University:

Raymond F Schinazi has contributed significantly to academic excellence and research at Emory University. His dual professorship reflects his interdisciplinary approach to tackling complex medical challenges.

2. Atlanta Veterans Affairs Medical Center:

His association with the Atlanta Veterans Affairs Medical Center has been crucial in pioneering groundbreaking research in the field of viral infections. This collaboration has furthered our understanding of various diseases and improved treatment options for veterans and the broader community.

Collaborations:

Raymond F Schinazi's work has been greatly enriched by collaborations with esteemed colleagues and researchers. Some of his notable coworkers include Dennis C Liotta and Chung K Chu. These collaborations have fostered an environment of innovation, allowing for the exchange of ideas and the development of novel treatment approaches.

Conclusion:

Raymond F Schinazi's extensive career in medical research and innovation has left an indelible impact on the field. With his insightful contributions to the treatment of viral infections and abnormal cellular proliferation, his innovative patents and collaborative efforts continue to pave the way for advancements in medical science. Raymond F Schinazi's dedication and commitment to improving the lives of patients worldwide truly make him a remarkable figure in the field of medical research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…